ReviewAnnals of medicine and surgery (2012)2025
Prostate cancer risk reduction: promising prevention practices and insights.
Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer is among the leading causes of cancer-related morbidity and mortality in men worldwide. Despite advancements in diagnostic and therapeutic approaches, prevention remains a critical strategy to curb its prevalence. This review examines promising prevention practices, including lifestyle modifications, dietary interventions, and the use of chemopreventive agents. It also delves into emerging insights from genetic, epigenetic, and molecular studies, offering a comprehensive framework for reducing prostate cancer risk through tailored and evidence-based approaches. Lifestyle changes, such as maintaining a healthy weight, engaging in regular physical activity, and adopting a plant-based diet, have shown substantial potential in mitigating prostate cancer risk. Specific dietary components, like antioxidants found in fruits and vegetables and omega-3 fatty acids in fish, demonstrate protective properties, while reducing the intake of red and processed meats is encouraged. Chemopreventive agents, including 5-alpha reductase inhibitors and anti-inflammatory medications, offer additional strategies but require careful assessment of risks and benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.